KIYATEC Announces Investment from Seae Ventures and Names Co-founder and Managing Partner Jason Robart to its Board of Directors
01 May, 2021
– Kaia Health, a NYC-based digital therapeutics company, raised $75m in Series C funding.
– The round was led by an unnamed growth equity fund with participation from existing investors Optum Ventures, Eurazeo, capital300, Balderton Capital, Heartcore Capital, Symphony Ventures (the investment vehicle of golf legend Rory McIlroy) and A Round Capital.
– The company will use the funds to grow its commercial team, accelerate product and partnership development and extend the offering within Europe.